Published in Blood Weekly, May 10th, 2007
Success with cancer radiotherapy is limited by damage to normal tissues, such as the hematopoietic/immune system. AEOL 10113 was studied to determine its ability to modify radiation induced effects on bone marrow-derived cells. Researchers observed greater increases in DNA synthesis in samples of whole blood taken 4 days...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.